TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agents

European Journal of Medicinal Chemistry

Volumn 45, Issue 2, 2010, Pages 840-845

  Juspin, Thierry ^a   Laget, Michèle ^a   Terme, Thierry ^a   Azas, Nadine ^a   Vanelle, Patrice ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Anti infectious; Imidazo 2,1 b thiazole; TDAE

Indexed keywords

1 ACETYL 3 HYDROXY 3 [(5 NITROIMIDAZO[2,1 B]THIAZOL 6 YL)METHYL]INDOLIN 2 ONE; 3 HYDROXY 1 METHYL 3 [(5 NITROIMIDAZO [2,1 B]THIAZOL 6 YL)METHYL]INDOLIN 2 ONE; 3 HYDROXY 3 [(5 NITROIMIDAZO[2,1 B]THIAZOL 6 YL)METHYL]INDOLIN 2 ONE; 6 BROMETHYL 5 NITROIMIDAZO[2,1 B]THIAZOLE; 6 BROMOMETHYL 5 NITROIMIDAZO[2,1 B]THIAZOLE; ANTIINFECTIVE AGENT; DIETHYL 2 HYDROXY 2 [(5 NITROIMIDAZO[2,1 B]THIAZOL 6 YL)METHYL]MALONATE; ETHYL 2 HYDROXY 2 METHYL 3 (5 NITROIMIDAZO[2,1 B]THIAZOL 6 YL)PROPANOATE; ETHYL 2 HYDROXY 3 (5 NITROIMIDAZO[2,1 B]THIAZOL 6 YL)PROPANOATE; ETHYL 3 (5 NITROIMIDAZO[2,1 B]THIAZOL 6 YL)ACRYLATE; ETHYL 3 BROMO 2 HYDROXY 2 [(5 NITROIMIDAZO[2,1 B]THIAZOL 6 YL)METHYL]PROPANOATE; ETHYLENE; IMIDAZO[2,1 B]THIAZOLE DERIVATIVE; LACTAM DERIVATIVE; MALONIC ACID; METHYL 3,3,3 TRIFLUORO 2 HYDROXY 2 [(5 NITROIMIDAZO[2,1 B]THIAZOL 6 YL)METHYL]PROPANOATE; TETRAKIS(DIMETHYL AMINO)ETHYLENE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; DISK DIFFUSION; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROCOCCUS HIRAE; ESCHERICHIA COLI; FUNGAL STRAIN; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HYDROLYSIS; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; YEAST;

ANTI-INFECTIVE AGENTS; BACTERIA; DIMETHYLAMINES; ETHYLENES; FUNGI; IMIDAZOLES; MICROBIAL SENSITIVITY TESTS; THIAZOLES;

EID: 73949154689     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.10.048     Document Type: Article

References (43)

1. Zaoutis T.E., Argon J., Chu J., Berlin J.A., Walsh T.J., and Feudtner C. Clin. Infect. Dis. 41 (2005) 1232-1239
2. Ruhnke M. Curr. Drug Targets 7 (2006) 495-504
3. Zhanel G.G., Karlowsky J.A., Zelenitsky S.A., Turik M.A., and Hoban D.J. Antimicrob. Agents Chemother. 42 (1998) 2446-2448
4. Coleman K. Drug Discov. Today Ther. Strateg. 37 (2004) 455-460
5. Odds F.C., Brown A.J.P., and Gow N.A.R. Trends Microbiol. 11 (2003) 272-279
6. Schuetzer-Muehlbauer M., Willinger B., Krapf G., Enzinger S., Presterl E., and Kuchler K. Mol. Microbiol. 48 (2003) 225-235
7. Mohan J., Anjaneyulu G.S.R., and Kiran Ms. Indian J. Chem. 27B (1988) 570-572
8. Paolini J.P., and Lendvay L.J. J. Med. Chem. 12 (1969) 1031-1034
9. Gupta G.D., Jain K.K., Gupta R.P., and Pujari H.K. Indian J. Chem. 22B (1983) 268-269
10. Robert J.F., Boukraa S., Panouse J.J., Loppinet V., and Chaumont J.P. Eur. J. Med. Chem. 25 (1990) 731-736
11. Amarouch H., Loiseau P.R., Bacha C., Caujolle R., Payard M., Loiseau P.M., Bories C., and Gayral P. Eur. J. Med. Chem. 22 (1987) 463-466
12. Andreani A., Bonazzi D., and Rambaldi M. Il Farmaco Ed. Sci. 35 (1980) 896-901
13. Andreani A., Bonazzi D., and Rambaldi M. Arch. Pharm. (Weinheim) 315 (1982) 451-456
14. Andreani A., Rambaldi M., Locatelli A., Bossa R., Fraccari A., and Galatulas I. Pharm. Acta Helv. 68 (1993) 21-24
15. Andreani A., Rambaldi M., Locatelli A., Bossa R., Fraccari A., and Galatulas I. J. Pharm. Belg. 48 (1993) 378-382
16. Andreani A., Rambaldi M., Leoni A., Locatelli A., Bossa R., Fraccati A., and Galatulas I. J. Med. Chem. 39 (1996) 2852-2855
17. Giuglio-Tonolo G., Terme T., Médebielle M., and Vanelle P. Tetrahedron Lett. 44 (2003) 6433-6435
18. Giuglio-Tonolo G., Terme T., Médebielle M., and Vanelle P. Tetrahedron Lett. 45 (2004) 5121-5124
19. Amiri-Attou O., Terme T., and Vanelle P. Synlett. 20 (2005) 3047-3050
20. Amiri-Attou O., Terme T., and Vanelle P. Molecules 10 (2005) 545-551
21. Montana M., Terme T., and Vanelle P. Tetrahedron Lett. 46 (2005) 8373-8376
22. Montana M., Terme T., and Vanelle P. Tetrahedron Lett. 47 (2006) 6573-6576
23. Amiri-Attou O., Terme T., Médebielle M., and Vanelle P. Tetrahedron Lett. 49 (2008) 1016-1020
24. Montana M., Crozet M.D., Castera-Ducros C., Terme T., and Vanelle P. Heterocycles 75 (2008) 925-932
25. Khoumeri O., Montana M., Terme T., and Vanelle P. Tetrahedron 64 (2008) 11237-11242
26. Juspin T., Terme T., and Vanelle P. Synlett. (2009) 1485-1489
27. Crozet M.P., Gellis A., Pasquier C., Vanelle P., and Aune J.P. Tetrahedron Lett. 36 (1995) 525-528
28. Roubaud C., Vanelle P., Maldonado J., and Crozet M.P. Tetrahedron 51 (1995) 9643-9656
29. Gellis A., Vanelle P., Kaafarani M., Benakli K., and Crozet M.P. Tetrahedron 53 (1997) 5471-5484
30. Szabo R., Crozet M.D., and Vanelle P. Synlett. (2008) 2836-2840
31. Vanelle P., De Meo M.P., Maldonado J., Nouguier R., Crozet M.P., Laget M., and Dumenil G. Eur. J. Med. Chem. 25 (1990) 241-250
32. Vanelle P., Crozet M.P., Maldonado J., and Barreau M. Eur. J. Med. Chem. 26 (1991) 167-178
33. Jentzer O., Vanelle P., Crozet M.P., Maldonado J., and Barreau M. Eur. J. Med. Chem. 26 (1991) 687-697
34. Delmas F., Gasquet M., Timon-David P., Madadi N., Vanelle P., Vaille A., and Maldonado J. Eur. J. Med. Chem. 28 (1993) 23-27
35. Upcroft J.A., Dunn L.A., Wright J.M., Benakli K., Upcroft P., and Vanelle P. Antimicrob. Agents Chemother. 50 (2006) 344-347
36. Vanelle P., Madadi N., Maldonaldo J., Giraud L., Sabuco J.F., and Crozet M.P. Heterocycles 32 (1991) 2083-2087
37. Gellis A., Njoya Y., Crozet M.P., and Vanelle P. Synth. Commun. 31 (2001) 1257-1262
38. Pooput C., Médebielle M., and Dolbier W.R. J. Org. Chem. 71 (2006) 3564-3568
39. Ait-Mohand S., Takechi N., Médebielle M., and Dolbier W.R. Org. Lett. 3 (2001) 4271-4273
40. Winkelmann E., Raether W., Hartung H., and Wagner W.H. Arzneim. Forsch. 27 (1977) 82-89
41. Bauer A.W., Kirby W.M., Sherris J.C., and Turck M. Am. J. Clin. Pathol. 45 (1966) 493-496
42. National Committee for Clinical Laboratory Standards, 2002, Performance Standards for antimicrobial susceptibility testing - Twelfth international supplement, M100-S12, Wayne, P.A.
43. National Committee for clinical Laboratory Standards, 2002, Method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard M27-A2, Wayne, P.A.